194 related articles for article (PubMed ID: 20693983)
21. Focal Anomalous Expression of Cytokeratin and p63 in Malignant Phyllodes Tumor: A Comparison With Spindle Cell Metaplastic Carcinoma.
Bansal M; Chen J; Wang X
Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):198-201. PubMed ID: 28968268
[TBL] [Abstract][Full Text] [Related]
22. The significance of enhancer of zeste homolog 2 (EZH2) expression in spindle cell lesions of the breast.
Genco IS; Hackman K; Morrar D; Jin C; Santagada E; Hajiyeva S
Pathol Int; 2021 Jun; 71(6):415-419. PubMed ID: 33730427
[TBL] [Abstract][Full Text] [Related]
23. GATA binding protein 3 (GATA3) as a marker for metaplastic spindle cell carcinoma of the breast.
Jin C; Hacking S; Sajjan S; Kamanda S; Bhuiya T; Nasim M
Pathol Res Pract; 2021 May; 221():153413. PubMed ID: 33770555
[TBL] [Abstract][Full Text] [Related]
24. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M
Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455
[TBL] [Abstract][Full Text] [Related]
25. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
[TBL] [Abstract][Full Text] [Related]
26. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
27. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
28. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
Meyer B; Stirzaker C; Ramkomuth S; Harvey K; Chan B; Lee CS; Karim R; Deng N; Avery-Kiejda KA; Scott RJ; Lakhani S; Fox S; Robbins E; Shin JS; Beith J; Gill A; Sioson L; Chan C; Krishnaswamy M; Cooper C; Warrier S; Mak C; Rasko JE; Bailey CG; Swarbrick A; Clark SJ; O'Toole S; Pidsley R
J Pathol; 2024 Apr; 262(4):480-494. PubMed ID: 38300122
[TBL] [Abstract][Full Text] [Related]
29. Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma.
Muller KE; Tafe LJ; de Abreu FB; Peterson JD; Wells WA; Barth RJ; Marotti JD
Hum Pathol; 2015 Feb; 46(2):327-33. PubMed ID: 25476122
[TBL] [Abstract][Full Text] [Related]
30. Wnt signaling pathway analysis in renal cell carcinoma in young patients.
Bruder E; Moch H; Ehrlich D; Leuschner I; Harms D; Argani P; Briner J; Graf N; Selle B; Rufle A; Paulussen M; Koesters R
Mod Pathol; 2007 Dec; 20(12):1217-29. PubMed ID: 17873895
[TBL] [Abstract][Full Text] [Related]
31. c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?
Carvalho S; e Silva AO; Milanezi F; Ricardo S; Leitão D; Amendoeira I; Schmitt FC
J Clin Pathol; 2004 Oct; 57(10):1075-9. PubMed ID: 15452163
[TBL] [Abstract][Full Text] [Related]
32. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
[TBL] [Abstract][Full Text] [Related]
33. Fibromatosislike metaplastic carcinoma of the breast as a diagnostic pitfall for fine needle aspiration cytology: a case report.
Jarboe E; Layfield LJ; Collins B
Acta Cytol; 2010; 54(5):712-6. PubMed ID: 20968161
[TBL] [Abstract][Full Text] [Related]
34. Superficial fibromatoses are genetically distinct from deep fibromatoses.
Montgomery E; Lee JH; Abraham SC; Wu TT
Mod Pathol; 2001 Jul; 14(7):695-701. PubMed ID: 11455002
[TBL] [Abstract][Full Text] [Related]
35. Malignant phyllodes tumour of the breast mimicking endometriosis.
Lee AHS; Zanetto U; Awasthi R; Hwang MJ; Nasir NDM; Ng CCY; Teh BT; Tan PH
Virchows Arch; 2021 Nov; 479(5):1051-1053. PubMed ID: 33782741
[TBL] [Abstract][Full Text] [Related]
36. Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours.
Karim RZ; Gerega SK; Yang YH; Horvath L; Spillane A; Carmalt H; Scolyer RA; Lee CS
J Clin Pathol; 2009 Nov; 62(11):1016-20. PubMed ID: 19861560
[TBL] [Abstract][Full Text] [Related]
37. Nuclear β-catenin immunoexpression in scars.
Goto K; Ishikawa M; Aizawa D; Muramatsu K; Naka M; Sugino T
J Cutan Pathol; 2021 Jan; 48(1):18-23. PubMed ID: 32652763
[TBL] [Abstract][Full Text] [Related]
38. Fine-needle aspiration cytology of spindle cell lesions of the breast.
Chhieng DC; Cangiarella JF; Waisman J; Fernandez G; Cohen JM
Cancer; 1999 Dec; 87(6):359-71. PubMed ID: 10603190
[TBL] [Abstract][Full Text] [Related]
39. Fibromatosis-like carcinoma-an unusual phenotype of a metaplastic breast tumor associated with a micropapilloma.
Rekhi B; Shet TM; Badwe RA; Chinoy RF
World J Surg Oncol; 2007 Feb; 5():24. PubMed ID: 17324295
[TBL] [Abstract][Full Text] [Related]
40. MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.
Lien HC; Huang CS; Yang YW; Jeng YM
APMIS; 2016 May; 124(5):356-64. PubMed ID: 26860948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
